Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.
about
11 C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)Multi-Target Directed Donepezil-Like Ligands for Alzheimer's DiseaseMetabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and TreatmentPredictive accuracy of amyloid imaging for progression from mild cognitive impairment to Alzheimer disease with different lengths of follow-up: a meta-analysis. [CorrectedPrimary age-related tauopathy (PART): a common pathology associated with human agingThe overlap between vascular disease and Alzheimer's disease--lessons from pathology.Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.APOEε2 is associated with milder clinical and pathological Alzheimer disease.Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.Multiple pathologies are common and related to dementia in the oldest-old: The 90+ Study.Cerebral amyloid angiopathy and its co-occurrence with Alzheimer's disease and other cerebrovascular neuropathologic changesDecreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease.Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer's disease brain.Ultrasound attacks Alzheimer's disease?Brain pathologies in extreme old age.Plaque-Associated Local Toxicity Increases over the Clinical Course of Alzheimer Disease.Tau positron emission tomographic imaging in aging and early Alzheimer diseaseSelective Attention and Sensory Modality in Aging: Curses and BlessingsCharacterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.The New Criteria for Alzheimer's Disease - Implications for GeriatriciansASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy.The Effect of Vascular Neuropathology on Late-life Cognition: Results from the SMART Project.Hippocampal phospho-tau/MAPT neuropathology in the fornix in Alzheimer disease: an immunohistochemical autopsy study.Challenges of multimorbidity of the aging brain: a critical update.Neurofibrillary Tangle Stage and the Rate of Progression of Alzheimer Symptoms: Modeling Using an Autopsy Cohort and Application to Clinical Trial Design.Tau Positron Emission Tomographic Imaging in the Lewy Body Diseases.Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's diseaseThal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.Seed-competent high-molecular-weight tau species accumulates in the cerebrospinal fluid of Alzheimer's disease mouse model and human patients.Neuropathological assessment and validation of mouse models for Alzheimer's disease: applying NIA-AA guidelines.Angiotensin Receptor Blocker Protects Alzheimer's Disease Brain From Ischemic Insult.18F PET with florbetapir for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).18F PET with florbetaben for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Aminopyrimidine Class Aggregation Inhibitor Effectively Blocks Aβ-Fibrinogen Interaction and Aβ-Induced Contact System Activation.Blood will out: vascular contributions to Alzheimer's disease.Failure analysis of clinical trials to test the amyloid hypothesis.Deciphering the Astrocyte Reaction in Alzheimer's Disease.Alzheimer dementia with sparse amyloid—AD mimic or variant?
P2860
Q24194742-83243905-1697-4153-9295-CDCE99108214Q26744105-9369F408-2D7E-4504-BB4B-41FB66F3166FQ26799893-6D4435B0-3F87-42E0-BA61-0730CCA72182Q27007436-528B6F1F-28DB-4E6F-9778-50DCD72D92D5Q34445021-57A2E845-46B8-419D-8F33-06E7EAF0B40DQ34484708-CB02A78D-F157-4D8C-A792-DAABECB98D25Q34833657-76856A4C-9E96-45CD-80DF-67D36CF8E91CQ35660968-8D04145B-94E0-4390-B812-37184C7EF24EQ35800785-F53E91FC-C382-459B-AF2C-96686F0BF491Q35966448-BB809D3B-A639-420C-B4D7-42554F56606EQ36037652-B9EB8CC3-CF28-4737-ABA7-F9E3DFE83D2DQ36137359-3FEE5D99-A342-44BB-A3AC-17376F5D915BQ36169754-115ED65C-5264-4B3B-9005-02E4E1EB0A1AQ36241902-7D8593F5-191F-4AC6-BD72-245BBAAF8024Q36395714-FD624097-0496-4EFE-A247-3ADE1495C629Q36509219-F6DDEAA9-46D7-4C18-B1BB-8A3AB3F8A325Q36535275-EC422E7C-24BC-4809-95D6-8715088423ECQ36747049-3F31274E-8D42-4602-BC6E-49AA526C002BQ36801792-D4AA707A-A491-4573-AF8A-215A722CEC3EQ37041385-6D975AED-0F31-48DE-9CA3-D57FD91CC9B3Q37043396-FD313101-E815-478D-BAD7-0B0692CCC013Q37305212-E13D13F4-EA21-4166-BFF5-DA2E987FF6CBQ37377931-7E2349E5-322F-4BD6-BC11-A1A69AEE3F35Q38236878-EDC31180-E008-444E-BCF1-D83746093A5CQ38911065-8FC501DC-9BA1-4B24-92E8-4CD2B82BA6B8Q39365272-E6EECFF8-FA30-4E27-B51A-09929CDA6C53Q39404969-3AD4BBB6-500B-414E-89E1-A9B9E776C85EQ39829758-51AA1C3F-5E4C-4D9D-8D8D-96108CC04E33Q41046533-B9635BE9-D034-4971-AEF4-1ADEE5C28731Q42643490-D1E4FD79-F710-419F-902C-4CD104E1FE88Q45862699-50062775-4902-4D75-9161-10C74318D93EQ47209544-B7C75142-8E92-4DE2-8F29-B80E384B1BFBQ47209556-1D58ED34-FF3F-4FEA-AB96-6A9DF4D29CACQ47209563-A401B8BF-9475-43C9-92BB-BFEC4B0D69E7Q49374917-F5EFE556-53FA-4413-A472-05DA324703F7Q49498166-325519D0-03D5-437E-AA3C-5353F136D114Q53354937-82ADD36C-9E9F-4113-9DFA-57F3E5A9F582Q55364689-2AC53FD5-03B8-419A-9AB5-FF57CD0DDA2FQ58035805-7FB263A4-A8B6-4C19-AFEA-9A5844C3F7FD
P2860
Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@en
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@nl
type
label
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@en
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@nl
prefLabel
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@en
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@nl
P2093
P2860
P1476
Examination of the clinicopath ...... Alzheimer Coordinating Center.
@en
P2093
Alberto Serrano-Pozo
Matthew P Frosch
Rebecca A Betensky
Sarah E Monsell
P2860
P304
P356
10.1097/NEN.0000000000000016
P577
2013-12-01T00:00:00Z